224 related articles for article (PubMed ID: 22082243)
61. Duffy blood group and malaria.
Langhi DM; Bordin JO
Hematology; 2006 Oct; 11(5):389-98. PubMed ID: 17607593
[TBL] [Abstract][Full Text] [Related]
62. Impact of Duffy polymorphisms on parasite density in Brazilian Amazonian patients infected by Plasmodium vivax.
Abou-Ali RK; Dhyani A; Terço AL; Toro DM; Gomes KS; Tezza LC; Negreiros MA; Batista CS; Souza MKS; Sanguino ECB; Albuquerque SRL
Malar J; 2019 Aug; 18(1):289. PubMed ID: 31455368
[TBL] [Abstract][Full Text] [Related]
63. A novel allele of the atypical chemokine receptor 1 (ACKR1) gene containing the nucleotide change c.126 T>G (p.42Glu) encodes a third Duffy blood group protein sequence antithetical to that encoding Fy
Weinstock C; Mytilineos J; Bugert P; Sitzmann N; Pensel E; Schrezenmeier H; Fürst D
Transfusion; 2019 Jun; 59(6):2158-2159. PubMed ID: 30848497
[No Abstract] [Full Text] [Related]
64. The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals.
Chaudhuri A; Polyakova J; Zbrzezna V; Pogo AO
Blood; 1995 Feb; 85(3):615-21. PubMed ID: 7833466
[TBL] [Abstract][Full Text] [Related]
65. Distribution of the FYBES and RHCE*ce(733C>G) alleles in an Argentinean population: implications for transfusion medicine.
Cotorruelo CM; Fiori SV; Borrás SE; Racca LL; Biondi CS; Racca AL
BMC Med Genet; 2008 May; 9():40. PubMed ID: 18460195
[TBL] [Abstract][Full Text] [Related]
66. Duffy blood group system: New genotyping method and distribution in a Brazilian extra-Amazonian population.
Martins ML; da Silva AR; Santos HC; Alves MT; Schmidt LC; Vertchenko SB; Dusse LMS; Silva Malta MCFD
Mol Cell Probes; 2017 Oct; 35():20-26. PubMed ID: 28587995
[TBL] [Abstract][Full Text] [Related]
67. Estimated prevalence of the Duffy null phenotype Fy (a-b-) among black blood-donors in Southwestern Colombia.
Quintero-Santacruz M; Flórez Elvira L; Mejía Hurtado AF; Macia Mejía C
Transfus Apher Sci; 2020 Dec; 59(6):102884. PubMed ID: 32718831
[TBL] [Abstract][Full Text] [Related]
68. Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease.
Afenyi-Annan A; Kail M; Combs MR; Orringer EP; Ashley-Koch A; Telen MJ
Transfusion; 2008 May; 48(5):917-24. PubMed ID: 18248572
[TBL] [Abstract][Full Text] [Related]
69. FY*X real-time polymerase chain reaction with melting curve analysis associated with a complete one-step real-time FY genotyping.
Ansart-Pirenne H; Martin-Blanc S; Le Pennec PY; Rouger P; Cartron JP; Tournamille C
Vox Sang; 2007 Feb; 92(2):142-7. PubMed ID: 17298577
[TBL] [Abstract][Full Text] [Related]
70. The Darc side of glycobiology in acute lung injury.
Reilly JP; Christie JD
Chest; 2012 May; 141(5):1132-1134. PubMed ID: 22553256
[No Abstract] [Full Text] [Related]
71. Two Genetically Distinct
Liew CC; Lau YL; Fong MY; Cheong FW
Am J Trop Med Hyg; 2020 May; 102(5):1068-1071. PubMed ID: 32189613
[TBL] [Abstract][Full Text] [Related]
72. High frequency of the erythroid silent Duffy antigen genotype and lack of Plasmodium vivax infections in Haiti.
Weppelmann TA; Carter TE; Chen Z; von Fricken ME; Victor YS; Existe A; Okech BA
Malar J; 2013 Jan; 12():30. PubMed ID: 23347639
[TBL] [Abstract][Full Text] [Related]
73. Identification of ACKR1 variants associated with altered Duffy phenotype expression in blood donors from southern Brazil.
Höher G; Rodrigues MMO; Waskow G; Agnes G; Von Burg PV; Onsten T; Fiegenbaum M; Almeida S
Transfus Apher Sci; 2020 Aug; 59(4):102768. PubMed ID: 32276863
[TBL] [Abstract][Full Text] [Related]
74. First example of an FY*01 allele associated with weakened expression of Fya on red blood cells.
Arndt PA; Horn T; Keller JA; Heri SM; Keller MA
Immunohematology; 2015; 31(3):103-7. PubMed ID: 26829175
[TBL] [Abstract][Full Text] [Related]
75. Duffy blood group genotypes among African-Brazilian communities of the Amazon region.
Perna SJ; Cardoso GL; Guerreiro JF
Genet Mol Res; 2007 Mar; 6(1):166-72. PubMed ID: 17469066
[TBL] [Abstract][Full Text] [Related]
76. Molecular mechanisms that lead to reduced expression of duffy antigens.
Yazdanbakhsh K; Rios M; Storry JR; Kosower N; Parasol N; Chaudhuri A; Reid ME
Transfusion; 2000 Mar; 40(3):310-20. PubMed ID: 10738032
[TBL] [Abstract][Full Text] [Related]
77. [Genotyping of Duffy Blood Group by Microchip Capillary Electrophoresis].
Wu F; Liang S; Zhuang NB; Liang YL; Su YQ; Hong WX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1733-1739. PubMed ID: 33067982
[TBL] [Abstract][Full Text] [Related]
78. Dinucleotide repeat in the 3' flanking region provides a clue to the molecular evolution of the Duffy gene.
Li J; Iwamoto S; Sugimoto N; Okuda H; Kajii E
Hum Genet; 1997 May; 99(5):573-7. PubMed ID: 9150720
[TBL] [Abstract][Full Text] [Related]
79. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor.
Peiper SC; Wang ZX; Neote K; Martin AW; Showell HJ; Conklyn MJ; Ogborne K; Hadley TJ; Lu ZH; Hesselgesser J; Horuk R
J Exp Med; 1995 Apr; 181(4):1311-7. PubMed ID: 7699323
[TBL] [Abstract][Full Text] [Related]
80. A novel FY*A allele with the 265T and 298A SNPs formerly associated exclusively with the FY*B allele and weak Fy(b) antigen expression: implication for genotyping interpretative algorithms.
Lopez GH; Condon JA; Wilson B; Martin JR; Liew YW; Flower RL; Hyland CA
Vox Sang; 2015 Jan; 108(1):52-7. PubMed ID: 25092430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
